| Glycyrrhizin prevents SARS-CoV-2 S1 and Orf3a induced high mobility group box 1 (HMGB1) release and inhibits viral replication P Gowda, S Patrick, SD Joshi, RK Kumawat, E Sen Cytokine 142, 155496, 2021 | 69 | 2021 |
| Mutant isocitrate dehydrogenase 1 disrupts PKM2–β-Catenin–BRG1 transcriptional network-driven CD47 expression P Gowda, S Patrick, A Singh, T Sheikh, E Sen Molecular and cellular biology, 2018 | 37 | 2018 |
| Hexokinase 2 and nuclear factor erythroid 2–related factor 2 transcriptionally coactivate xanthine oxidoreductase expression in stressed glioma cells T Sheikh, P Gupta, P Gowda, S Patrick, E Sen Journal of Biological Chemistry 293 (13), 4767-4777, 2018 | 31 | 2018 |
| Lactate induced HIF-1α-PRMT1 cross talk affects MHC I expression in monocytes P Gupta, A Singh, P Gowda, S Ghosh, A Chatterjee, E Sen Experimental Cell Research 347 (2), 293-300, 2016 | 21 | 2016 |
| MCL-1 is a master regulator of cancer dependency on fatty acid oxidation MS Prew, U Adhikary, DW Choi, EP Portero, JA Paulo, P Gowda, ... Cell reports 41 (1), 2022 | 20 | 2022 |
| PRMT1 driven PTX3 regulates ferritinophagy in glioma K Lathoria, P Gowda, SB Umdor, S Patrick, V Suri, E Sen Autophagy 19 (7), 1997-2014, 2023 | 15 | 2023 |
| Rewiring of lactate–interleukin-1β autoregulatory loop with clock-Bmal1: a feed-forward circuit in glioma P Gowda, K Lathoria, S Sharma, S Patrick, SB Umdor, E Sen Molecular and Cellular Biology, 2021 | 13 | 2021 |
| YAP1-mediated regulation of mitochondrial dynamics in IDH1 mutant gliomas S Patrick, P Gowda, K Lathoria, V Suri, E Sen Journal of Cell Science 134 (22), jcs259188, 2021 | 12 | 2021 |
| Repurposing methotrexate in dampening SARS-CoV2-S1-mediated IL6 expression: lessons learnt from lung cancer P Gowda, S Patrick, SD Joshi, RK Kumawat, E Sen Inflammation, 1-8, 2022 | 6 | 2022 |
| A road map for the treatment of pediatric diffuse midline glioma C Koschmann, WN Al-Holou, MM Alonso, J Anastas, P Bandopadhayay, ... Cancer cell 42 (1), 1-5, 2024 | 5 | 2024 |
| Brg1 mutation alters oxidative stress responses in glioblastoma P Gowda, K Lathoria, SB Umdor, E Sen Neurochemistry International 150, 105189, 2021 | 5 | 2021 |
| Dipg-28. Identification and targeting of metabolic vulnerabilities in combination with pdgfra-inhibition in diffuse midline glioma S Neyazi, PS Gowda, M Trissal, JM Fonticella, EP Portero, JP Haley-Read, ... Neuro-Oncology 25 (Suppl 1), i19, 2023 | 1 | 2023 |
| Dynamic modelling predicts lactate and IL-1β as interventional targets in metabolic-inflammation-clock regulatory loop in glioma S Sharma, P Gowda, K Lathoria, MK Mitra, E Sen Integrative Biology 15, zyad008, 2023 | 1 | 2023 |
| DIPG-14. METABOLIC REPROGRAMMING AS A RESISTANCE MECHANISM IN DIFFUSE MIDLINE GLIOMA S Neyazi, P Gowda, SC Frederico, CM Nguyen, MC Trissal, EP Portero, ... Neuro-Oncology 26 (Suppl 4), 0, 2024 | | 2024 |
| Revealing and targeting metabolic drivers contributing to treatment escape in diffuse midline glioma. SC Frederico, S Neyazi, P Gowda, C Nguyen, M Trissal, EP Portero, ... Journal of Clinical Oncology 42 (16_suppl), 10038-10038, 2024 | | 2024 |
Ellora SenNational Brain Research Center在 nbrc.ac.in 的电子邮件经过验证
